We&Win Diversification Co Ltd (4113) - Cash Flow Conversion Efficiency
Based on the latest financial reports, We&Win Diversification Co Ltd (4113) has a cash flow conversion efficiency ratio of -0.061x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-258.80 Million ≈ $-8.15 Million USD) by net assets (NT$4.27 Billion ≈ $134.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
We&Win Diversification Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how We&Win Diversification Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read We&Win Diversification Co Ltd (4113) total liabilities for a breakdown of total debt and financial obligations.
We&Win Diversification Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of We&Win Diversification Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Builddirect.com Tehcnologies Inc
V:BILD
|
-0.025x |
|
Spheria Emerging Companies Ltd
AU:SEC
|
0.041x |
|
Kaiser Reef Ltd
AU:KAU
|
0.112x |
|
Klingon Aerospace Inc
TW:1529
|
-0.026x |
|
Xtra-Gold Resources Corp
TO:XTG
|
0.190x |
|
Uttam Sugar Mills Limited
NSE:UTTAMSUGAR
|
0.826x |
|
DPSC Limited
NSE:DPSCLTD
|
0.058x |
|
Saga Pure ASA
OL:SAGA
|
0.177x |
Annual Cash Flow Conversion Efficiency for We&Win Diversification Co Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of We&Win Diversification Co Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see market value of We&Win Diversification Co Ltd.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$4.27 Billion ≈ $134.43 Million |
NT$-2.92 Billion ≈ $-91.95 Million |
-0.684x | -239.56% |
| 2024-12-31 | NT$4.52 Billion ≈ $142.55 Million |
NT$2.22 Billion ≈ $69.87 Million |
0.490x | +262.79% |
| 2023-12-31 | NT$3.11 Billion ≈ $98.08 Million |
NT$-937.22 Million ≈ $-29.53 Million |
-0.301x | +34.45% |
| 2022-12-31 | NT$3.26 Billion ≈ $102.67 Million |
NT$-1.50 Billion ≈ $-47.16 Million |
-0.459x | -1233.09% |
| 2021-12-31 | NT$3.49 Billion ≈ $109.87 Million |
NT$141.35 Million ≈ $4.45 Million |
0.041x | +107.33% |
| 2020-12-31 | NT$3.42 Billion ≈ $107.65 Million |
NT$-1.89 Billion ≈ $-59.55 Million |
-0.553x | -473.46% |
| 2019-12-31 | NT$3.52 Billion ≈ $110.99 Million |
NT$521.83 Million ≈ $16.44 Million |
0.148x | +280.99% |
| 2018-12-31 | NT$3.73 Billion ≈ $117.54 Million |
NT$145.05 Million ≈ $4.57 Million |
0.039x | +135.02% |
| 2017-12-31 | NT$3.61 Billion ≈ $113.60 Million |
NT$-400.30 Million ≈ $-12.61 Million |
-0.111x | -- |
About We&Win Diversification Co Ltd
We & Win Diversification Co., Ltd. engages in the rental and sale of real estate properties in Taiwan. It is also involved in the public facilities construction investment; new towns and community development; wholesale of medical equipment; and international trade businesses. The company was formerly known as Oncoprobe Biotech Inc. and changed its name to We & Win Diversification Co., Ltd. in 20… Read more